Drugmaker Declines FDA Request to Pull Treatment After Patient Deaths

Sarepta stopped shipping Elevidys to non-ambulatory patients earlier this year.
Drugmaker Declines FDA Request to Pull Treatment After Patient Deaths
The U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times
Zachary Stieber
Zachary Stieber
Senior Reporter
|Updated:
0:00
Update: Sarepta is halting all shipments of Elevidys.

Original story below.

Zachary Stieber
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
twitter
truth